RECIPROCAL RELATIONSHIP BETWEEN THE LEVEL OF CIRCULATING CORTISOL ANDGROWTH-HORMONE SECRETION IN RESPONSE TO GROWTH HORMONE-RELEASING HORMONE IN MAN - STUDIES IN PATIENTS WITH ADRENAL INSUFFICIENCY
A. Giustina et al., RECIPROCAL RELATIONSHIP BETWEEN THE LEVEL OF CIRCULATING CORTISOL ANDGROWTH-HORMONE SECRETION IN RESPONSE TO GROWTH HORMONE-RELEASING HORMONE IN MAN - STUDIES IN PATIENTS WITH ADRENAL INSUFFICIENCY, The Journal of clinical endocrinology and metabolism, 79(5), 1994, pp. 1266-1272
The aim of our study was to elucidate the relationship between the lev
el of circulating cortisol and the GH responsiveness to GHRH in six hy
poadrenal patients (one male and five females; age range, 35-67 yr; bo
dy mass index range, 18-31 kg/m(2)). Twenty-four hours after taking th
e last dose of replacement therapy, each patient underwent the followi
ng experimental trials on nonconsecutive days: I) saline, and 2) 12.5
mg, or 3) 25 mg, or 4) 250 mg hydrocortisone hemisuccinate in 250 mt s
aline constant iv infusion from 0-180 min. On each occasion, 1 mu g/kg
human GHRH-(1-29)NH2 was injected as an iv bolus at 60 min. During GH
RH and saline infusion, serum cortisol levels mere always less than th
e detection limit of the assay (55 nmol/L). During 12.5-, 25-, and 250
-mg hydrocortisone infusions (from 15-180 min), serum cortisol average
d 413.8 +/- 19.3, 772.5 +/- 46.9, and 1520.2 +/- 110.4 nmol/L, respect
ively. The GH peaks after GHRH treatment during the various infusions
of hydrocortisone were compared to the GH peaks observed after saline,
which were normalized to 100% in each subject. GH peaks after GHRH an
d 25 mg hydrocortisone (70 +/- 11%) and GHRH and 250 mg hydrocortisone
(69 +/- 7%) were significantly (P < 0.05) lower than the GH peaks aft
er GHRH and saline or GHRH and 12.5 mg hydrocortisone (83 +/- 15%). No
significant differences were observed between the GK peaks after GHRH
and 12.5 mg hydrocortisone or GHRH and saline. Our data demonstrate t
hat in hypoadrenal patients, the acute absence of circulating cortisol
does not impair the GH secretory response to GHRH with respect to the
eucortisolemic state. Moreover, our data suggest that 700 nmol/L is t
he approximate threshold serum cortisol concentration above which a de
crease in the GH responsiveness to GHRH is observed in humans. Further
increases in serum cortisol levels above this threshold value do not
cause a proportional decrease in the GH responsiveness to GHRH.